New Delhi, 21/12: Covid-19 vaccine maker Moderna does not expect any problems in developing a booster shot to protect against the Omicron variant of the coronavirus and could begin work in a few weeks, Chief Executive Stephane Bancel said in an interview.
Moderna hopes to start clinical trials early next year on a vaccine to protect against the fast-spreading Omicron variant but for now, is focussing on a booster dose of its current mRNA-1273 vaccine. “It only needs minor adjustments for Omicron. I don’t expect any problems,” Bancel said in an interview with the Swiss newspaper TagesAnzeiger published on Tuesday.
Comments are closed.